| Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
|---|---|---|---|---|---|---|
| Vifa3g02961 | ATGTCTTCCTCCTCCGAAAGCCGTCGCAAATTTGACTCCAGATCTAGTAGTGGTCCAAACAGGAGGAGGTACAACGTGTTCTTGAGTTTCTGCGCTACAGATGCCGGACAGCTTGTTCCCCGTCTCTGTAGCGCTCTTAGTTGGGAACCTGGAATTGTTGTTTTTGGGGAAGACGAGAGGTTTCAACATAGGGAACATGTAGAGTCAGTGCTGAATGTAATTGGAGAATGCCAAATGGCTATTGTTGTATTTTCAATAAATTATACTAATTCCAGTTCGTGTATTCAAGAATTGGAGAAAATAACCGAGTGTTGTCGAACCTCCGATTTACGTGTTCTTCCCTTGTTTTATGATGTTGTTCATGCCTCCTACGGAAGTTTAAAGGAAGATATGTTTGGAGAGTCTTTTCCTAGTTTCCTTGATAGAATATCCATGAAGGAAATCTCTGAAAATGAAGATAAGTTCATGACTTGGGTGGCTTTGATAACTAAACCTACCGAATATTTAGAATCAATTGATCTCCTACACAAACCCACGCACATGTATGGAAATGTAAACATTGGGGAAATAGTTGAAGGTGTTACGTTTGTGATAAACAGAAGAAAGTTGTTGTTTAAGGCTTTCCCTGCACCGAGGGCAAAATCTAGTGTGGAAGATGTGGTTCAACTATTGAAACAATCAAAATCTCCTCTCCTACTAGGGATATGGGGGATGACAGGGATCGGTAAATCAACCATTGCCCAAACCACTTTTGCTCAAATTGGTCTTTACTTTGAATACGCGTGCTTCCTCCGAAACATTGCGGAACTTTGGAAAAACAATATTGGTAGAGTTTCATTACTAGACGAACTTCTTTCCATTATTGACGGACCAACTAAAATACGTATGCCCACAATTAAGTCAATGAAAGTGATCATAAAACAAAGTCTTCGACATAAAAGAATACTTCTTGTACTTGATGGTGTTGATAGATTGGAGCAGCTACATGCTTTGTGTGGAAGTCGTGAATGGTTTGGTGAAGGTAGCAAAATAATCATCACGACAAGAGACAGACATCTACTCAAGGAGCATGGAGTTGACCATATATATCAAGTGAAACTATTGGATCAAAGTAAGTCACTCAAGGTTTTGAATTCGGGTGCATTCGGCCAAGCACAGAATCCTCGAGAAGATTTTGTTGAAGTTTCTAGACAACTAGTTCCTTATTGTGGGGGATTACCTCTTGCTCTTGAAGCCCTTGGGATGTTCTTGCGTGGAAAGGAAGTACTTGAATGGAAGGGTGTGTTGAGGAGTCTCCAAAGATTTTCCATTCCAGTTCCACGACTACTAAATACTCTAGAAAAGAGTTTTAGTAATTTGAGTAATGAAGAGAAATGCATATTCCTTGATATAGCACATTTCTTTATAGGGATGAACCAAAATGATGTACTCCAAACATTAAATAGGTCAACACAATCCGCAGCTCTTCAAATAAGTTTCCTTCAAGACAAGAGCTTTGTAACCATTGATGAGAATAACAAACTTGAAATGCCTGTTCTGCTACAAGCCATGGCAAGTCAAATCATTAAGAAGGAATCAAGTAATAAGACTGATCAGCCAAAGAAATACGATGTGTTTTTGAGTTTCAGAGGGGAAGACAATCGGGCAAAGTTTGTGTCACATCTCCATTCCTCTCTTCAAAATGCAGGGGTTTATGTTTTCAAAGATGACGACGAGATTCAACGAGGAGATCAGATCTCATTCTCACTGTTGCAAGCAATTGGAAAGTCTAGAATTTCAATCGTTGTTTTGTCTACAAATTATGCTAATTCTAGATGGTGTATGCTAGAGTTGGAGAAGATCATGGAAATTGGCAGGGTCAAGGGTCTGGTGGTCGTGCCAGTGTTCTATGAGGTAGATCCCTCAGAAGTACGTCACCAGAAAGGTCGTTTTGGAAAAGCTTTTGAAGGTCTTATATCAACAACAATCTCAGTGGATAAATCTACCAAGAGTAATTGGAGAAAAGAACTCTTTGATATCGGTGGCATAGGAGGGTTTGTACTCGTAGATTCCAGGAATGAAAGTGGTGATATCAAGAATATTGTTGAACATGTTACTCGTTTGCTAGACAGAACAGAGTTATTTGTTGCTGAACATGCAGTGGGAATTGAATCTCGTGTGCAAGCTGCAACTAAGCTTTTAAACATCCAAAAAGCAGAAGATGTTTTACTTCTAGGGATATGGGGCATGGGGGGTATGGGAAAAGCAACCATTGCCAAAGCCATTTATAATAAAATTGGGAGCAAATTTGAGGGAAAGAGCTTCCTTTTGAATATAAGGGAATTTTGGGAAATGGATACTAATCAAGTCTCATTACAACAACAGGTACTTTGTGATGTTTACAAAACAACTTCATTCAAGATACGTGACATTGAGTCAGGGAAAAATATATTGAAGCAAAGACTTGGCCAAAAAAGGGTTCTGTTTGTGCTTGATGATGTGAATGAACTGGACCAACTAAAGGCTTTGTGTGGAAGCCGCAAATGGTTTGGTTCAGGGAGTAGAATAATCATTACAACAAGAGATATGCATCTTCTTAGATCGTGTAGAGTTGATCAAGTGTATAAAATAGAAGAAATGGACGAAAGTGAATCTCTTGAGCTTTTTAGTTGGCATGCATTCAAGCAACCAAGTCCGGAAGAAGATTTTGCTACACCTTCATCCAATGTGGTTGCTTACTCTGGGAGATTGCCACTAGCACTTGAAGTCCTTGGCTCCTATTTGTCTGACTGTGAAATAACAGAGTGGCACAAAGTTTTGGAGAAGCTCAAATGTATCCCCCATGATCAAGTACAGAAGAAGCTAAGAGTAAGCTTCGATGGTTTAAAAGATGTTACGGAGCAACAAATATTTCTTGATATAGCTTGTTTTTTTATTGGGATGGACCGAAATGATGTCATACAAATATTAAATTCGTGTGGATTTTTTGCCGATATTGGAATTAAAGTCCTTGTAGAGCGAAGCCTTGTAACTGTTGACAACAAGAACAAACTTAGAATGCATGATTTGCTGAGAGACATGGGAAGACAAATAATATATGAGGAATCTCCATTTGATCCTGAGAACCGCAGTAGGTTGTGGCGCCGTGAGGAAGTGTTTGATATATTATCAAAGCAAAAGGGAACTGAAGCTGTCAAGGGTCTGACTCTGGAGTTTCCAGGAAAAAATACAGTTTGTCTGAATACCAATGCATTTAAGAAGATGAATAAACTCAGATTGCTTCAACTTGCTGGCGTACAGCTTAATGGACATTTTAAAAATCTTTCGGGAGATCTTAGGTGGTTGTACTGGCATGGATTTCCGTCAACTTACACTCCTGCAGGATTTCAGCAAGGAAGTCTAGTTGTTGTCGAATTAAAATATAGTAATCTCAAACAAATATGGAAGAAGAGCCAGATGCTAGAGAATCTAAAAATTCTTAATCTTAGTCATTCTCGGGATTTGACTGAAACCCCCGATTTTTCATGCTTGCCAAATCTTGAAAAGCTAGTACTCAAAGACTGTCCAAGTTTGTCTACGGTCTCCCATAGCATTGGATCTCTCCGTAAAATTCTTCTTATTAATTTGACAGACTGCACAGGTCTTCGAGAACTTCCTAGAAGCATCTATAAATTAAAATCTCTAGAAACTTTGATTCTTTCCGGATGTTCCATGATCAACAGATTGGAGGAAGACATGGAACAAATGGAATCATTGACAACCTTGATTGCAGATAAGACTGCAATAACAAAAGTGCCTTTTTCAATAGTAAGATCGAAAAACATTGGATACATTTCTTTATGTGGCTTTGAAGGATTTTCACGTGATGTATTTCCTTCTATCATTCGGTCTTGGATGTCACCATCAAAGAATTTGATATCTCTAGTTCAAACATATGTGCCCACATCATCTCTTGGTACTTTCAAGGACCTTCCAAAGCTTCGAAGTCTTTGTGTAGAGTGCGGCTCTAAACAACAACTAAGTCGAGATGTGGCAAATATTTTGGATGTATTAAAAGCTACAAATTGTCATAAATTGGATGCAAGGGCAACTACGTCACAAATCTATGATACATTTCCTTCTCCTTTAATTGATGATTGCCTTGGTGAAGTTCGCACTTCAGGGTCAAAGAATTACTTGAAATCTTTCTTAATTCAAATGGGAACGAAATGCCAAGTATCCAATATTGCCGAAGACAACATTATACAGACAGCAGACGGGACTTGGGATTCATTTTTGCTCCCCTGTGACAATATATCTGATTGGTTAAACTTCAGTTGCAAAGGTAGTTCTGTAATATTTGTTGTCCCGGCAATCAAAGGGTGTATCCTGAAGAGTATGATGTTGTTTGTCCGCTATTACTCTTCCCCAGACAACATAATATCAGAAGGTTGCGATGGTATGTTGGTCGTAAATTACACAAAGACAACCATTCAGGTCTATAAAAGAGATACACTAATCTCCTTTGAGGATGGTGATTGGCAAAGTATTACAGCAAATCTAGAACCTGGTGACGAAGTGGAGGTTATGGTTGTTTTTGGGGAGGGGTTCATTGTCGAGGAGACAACAATATATCTCTTATATGATGAACCAATCAACCAAGAAATGGAAAACTGTAATGCAGTAGATGAGGAGGATGTTATTGTTTATTATGGTCATGATGAGGAGGATGTTAGTGTATCTGGTGGTTATAATACTGATGTACCAGTGGAAAACATTGCTACTGGTCTTGGTCAAGATGAAAATATAAGTGAAGATAGGCGCATGCATGCAATGGATAAGAATTCTGATGATGTTGCCAATGCCATGGCAACAAATAAGAAACGTGCCTGCTGTTTCTGGTGGCGGTGA | 4869 | 0.3894 | MSSSSESRRKFDSRSSSGPNRRRYNVFLSFCATDAGQLVPRLCSALSWEPGIVVFGEDERFQHREHVESVLNVIGECQMAIVVFSINYTNSSSCIQELEKITECCRTSDLRVLPLFYDVVHASYGSLKEDMFGESFPSFLDRISMKEISENEDKFMTWVALITKPTEYLESIDLLHKPTHMYGNVNIGEIVEGVTFVINRRKLLFKAFPAPRAKSSVEDVVQLLKQSKSPLLLGIWGMTGIGKSTIAQTTFAQIGLYFEYACFLRNIAELWKNNIGRVSLLDELLSIIDGPTKIRMPTIKSMKVIIKQSLRHKRILLVLDGVDRLEQLHALCGSREWFGEGSKIIITTRDRHLLKEHGVDHIYQVKLLDQSKSLKVLNSGAFGQAQNPREDFVEVSRQLVPYCGGLPLALEALGMFLRGKEVLEWKGVLRSLQRFSIPVPRLLNTLEKSFSNLSNEEKCIFLDIAHFFIGMNQNDVLQTLNRSTQSAALQISFLQDKSFVTIDENNKLEMPVLLQAMASQIIKKESSNKTDQPKKYDVFLSFRGEDNRAKFVSHLHSSLQNAGVYVFKDDDEIQRGDQISFSLLQAIGKSRISIVVLSTNYANSRWCMLELEKIMEIGRVKGLVVVPVFYEVDPSEVRHQKGRFGKAFEGLISTTISVDKSTKSNWRKELFDIGGIGGFVLVDSRNESGDIKNIVEHVTRLLDRTELFVAEHAVGIESRVQAATKLLNIQKAEDVLLLGIWGMGGMGKATIAKAIYNKIGSKFEGKSFLLNIREFWEMDTNQVSLQQQVLCDVYKTTSFKIRDIESGKNILKQRLGQKRVLFVLDDVNELDQLKALCGSRKWFGSGSRIIITTRDMHLLRSCRVDQVYKIEEMDESESLELFSWHAFKQPSPEEDFATPSSNVVAYSGRLPLALEVLGSYLSDCEITEWHKVLEKLKCIPHDQVQKKLRVSFDGLKDVTEQQIFLDIACFFIGMDRNDVIQILNSCGFFADIGIKVLVERSLVTVDNKNKLRMHDLLRDMGRQIIYEESPFDPENRSRLWRREEVFDILSKQKGTEAVKGLTLEFPGKNTVCLNTNAFKKMNKLRLLQLAGVQLNGHFKNLSGDLRWLYWHGFPSTYTPAGFQQGSLVVVELKYSNLKQIWKKSQMLENLKILNLSHSRDLTETPDFSCLPNLEKLVLKDCPSLSTVSHSIGSLRKILLINLTDCTGLRELPRSIYKLKSLETLILSGCSMINRLEEDMEQMESLTTLIADKTAITKVPFSIVRSKNIGYISLCGFEGFSRDVFPSIIRSWMSPSKNLISLVQTYVPTSSLGTFKDLPKLRSLCVECGSKQQLSRDVANILDVLKATNCHKLDARATTSQIYDTFPSPLIDDCLGEVRTSGSKNYLKSFLIQMGTKCQVSNIAEDNIIQTADGTWDSFLLPCDNISDWLNFSCKGSSVIFVVPAIKGCILKSMMLFVRYYSSPDNIISEGCDGMLVVNYTKTTIQVYKRDTLISFEDGDWQSITANLEPGDEVEVMVVFGEGFIVEETTIYLLYDEPINQEMENCNAVDEEDVIVYYGHDEEDVSVSGGYNTDVPVENIATGLGQDENISEDRRMHAMDKNSDDVANAMATNKKRACCFWWR | 1622 |
| Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
|---|---|---|---|---|---|---|---|---|
| Vifa3g02961 | 1622 | SUPERFAMILY | Toll/Interleukin receptor TIR domain | 527 | 670 | IPR035897 | - | |
| Vifa3g02961 | 1622 | SUPERFAMILY | P-loop containing nucleoside triphosphate hydrolases | 218 | 464 | IPR027417 | - | |
| Vifa3g02961 | 1622 | Gene3D | - | 701 | 868 | IPR027417 | - | |
| Vifa3g02961 | 1622 | Gene3D | - | 201 | 361 | IPR027417 | - | |
| Vifa3g02961 | 1622 | ProSiteProfiles | TIR domain profile. | 534 | 684 | IPR000157 | GO:0007165 | |
| Vifa3g02961 | 1622 | SUPERFAMILY | L domain-like | 1012 | 1326 | - | - | |
| Vifa3g02961 | 1622 | SUPERFAMILY | Toll/Interleukin receptor TIR domain | 14 | 120 | IPR035897 | - | |
| Vifa3g02961 | 1622 | PRINTS | Disease resistance protein signature | 737 | 752 | - | - | |
| Vifa3g02961 | 1622 | PRINTS | Disease resistance protein signature | 1145 | 1161 | - | - | |
| Vifa3g02961 | 1622 | PRINTS | Disease resistance protein signature | 814 | 828 | - | - | |
| Vifa3g02961 | 1622 | PRINTS | Disease resistance protein signature | 907 | 921 | - | - | |
| Vifa3g02961 | 1622 | Gene3D | - | 17 | 198 | IPR035897 | - | |
| Vifa3g02961 | 1622 | Gene3D | - | 528 | 700 | IPR035897 | - | |
| Vifa3g02961 | 1622 | ProSiteProfiles | TIR domain profile. | 22 | 147 | IPR000157 | GO:0007165 | |
| Vifa3g02961 | 1622 | Pfam | NB-ARC domain | 215 | 438 | IPR002182 | GO:0043531 | |
| Vifa3g02961 | 1622 | Pfam | NB-ARC domain | 720 | 942 | IPR002182 | GO:0043531 | |
| Vifa3g02961 | 1622 | SMART | AAA_5 | 229 | 369 | IPR003593 | GO:0016887 | |
| Vifa3g02961 | 1622 | SMART | AAA_5 | 734 | 871 | IPR003593 | GO:0016887 | |
| Vifa3g02961 | 1622 | FunFam | Disease resistance protein (TIR-NBS-LRR class) | 532 | 704 | - | - | |
| Vifa3g02961 | 1622 | PANTHER | LEUCINE-RICH REPEAT-CONTAINING PROTEIN | 536 | 1356 | IPR044974 | GO:0006952 | |
| Vifa3g02961 | 1622 | SUPERFAMILY | P-loop containing nucleoside triphosphate hydrolases | 700 | 967 | IPR027417 | - | |
| Vifa3g02961 | 1622 | SMART | till_3 | 23 | 165 | IPR000157 | GO:0007165 | |
| Vifa3g02961 | 1622 | SMART | till_3 | 535 | 676 | IPR000157 | GO:0007165 | |
| Vifa3g02961 | 1622 | Gene3D | - | 872 | 956 | IPR042197 | - | |
| Vifa3g02961 | 1622 | Gene3D | - | 367 | 454 | IPR042197 | - | |
| Vifa3g02961 | 1622 | Gene3D | Ribonuclease Inhibitor | 1054 | 1372 | IPR032675 | - | |
| Vifa3g02961 | 1622 | Pfam | TIR domain | 535 | 699 | IPR000157 | GO:0007165 | |
| Vifa3g02961 | 1622 | Pfam | TIR domain | 24 | 126 | IPR000157 | GO:0007165 |
| Select | Gene | Chromosome | Start | End | Duplicated_type |
|---|---|---|---|---|---|
| Vifa3g02961 | Vifa-Chr3 | 833520655 | 833530480 | Dispersed/Transposed |
| Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
|---|---|---|---|---|---|---|---|---|
| Vifa3g02961 | 217 | 529 | WRKY Transcription Factor Family | AT4G12020 | 33.019 | 1.94e-36 | 149 |
| Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
|---|---|---|---|---|---|---|
| Vifa3g02961 | - | - | mtr:11411578 | 2187.53 |